Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss Baker, James S. O’Donnell, Rezan A. Kadir et al.|Journal of Thrombosis and Haemostasis|2024Cited by 51
The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn Malec, Margaret V. Ragni, Dunlei Cheng et al.|American Journal of Hematology|2020Cited by 31
Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United StatesLynn Malec, Margaret V. Ragni, Char Witmer et al.|Blood|2018Cited by 2
A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with Hemophilia A: Results from the PREDICT StudyDoris V.K. Quon, Jessica Charlet, Miguel Escobar et al.|Advances in Therapy|2026Cited by 0